BOB体育

Skip to main content
(352) 265-0820

Mohammed Ruzieh, MD

Cardiologist (Heart Specialist)

Photo of Mohammed Ruzieh
(352) 265-0820 MyUFHealth

Research at a glance

Top areas of exploration

  • Postural Orthostatic Tachycardia Syndrome , 7 publications
  • Pulmonary Embolism , 6 publications
  • Cardiovascular Diseases , 5 publications
  • Biomarkers , 4 publications

Research activity

71 publications

359 citations

Why is this important?

Active clinical trials

Librexia AF

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-central nervous system (CNS) systemic embolism.

Investigator
Mohammed Ruzieh
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

71 publications

2023

Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic review: A systematic review of 尾B in COPD.

Trends in cardiovascular medicine

鈥�

2023

Clinical presentation and neurovascular manifestations of cardiac myxomas and papillary fibroelastomas: a retrospective single-institution cohort study.

Frontiers in cardiovascular medicine

鈥�

2023

Dysphagia aortica presenting as failure of performing transoesophageal echocardiogram

European Heart Journal - Case Reports

鈥�

2023

Editorial commentary: Resting heart rate and outcomes: Risk marker or risk factor?

Trends in Cardiovascular Medicine

2023

Impact of Baseline Heart Failure on Acute Pulmonary Embolism Risk Stratification and Clinical Outcomes.

The American journal of cardiology

鈥�